Multiple sclerosis patients report some relief in pot trial.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Zajicek, J. et al. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicnetre randomised placebo-controlled trial. The Lancet, 362, 1517 - 1526, (2003).
Related links
Rights and permissions
About this article
Cite this article
Pearson, H. Cannabis study shows small MS benefit. Nature (2003). https://doi.org/10.1038/news031103-14
Published:
DOI: https://doi.org/10.1038/news031103-14